QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference

Rhea-AI Summary

QuidelOrtho (Nasdaq: QDEL) said members of its management team will present at the Raymond James 47th Annual Institutional Investor Conference on Tuesday, March 3, 2026 at 1:40 p.m. ET / 10:40 a.m. PT.

According to the company, a live webcast and replay will be available in the Events & Presentations section of its Investor Relations website.

News Market Reaction – QDEL

+4.45%

14 alerts

+4.45% News Effect

+2.4% Peak in 3 hr 58 min

+$72M Valuation Impact

$1.68B Market Cap

0.4x Rel. Volume

On the day this news was published, QDEL gained 4.45%, reflecting a moderate positive market reaction. Argus tracked a peak move of +2.4% during that session. Our momentum scanner triggered 14 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $72M to the company's valuation, bringing the market cap to $1.68B at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Conference date: March 3, 2026 Presentation time (ET): 1:40 p.m. ET Presentation time (PT): 10:40 a.m. PT +1 more

4 metrics

Conference date March 3, 2026 Raymond James 47th Annual Institutional Investor Conference presentation

Presentation time (ET) 1:40 p.m. ET Scheduled slot at Raymond James conference

Presentation time (PT) 10:40 a.m. PT Scheduled slot at Raymond James conference

Conference edition 47th Annual Raymond James Institutional Investor Conference

Market Reality Check

Price: $22.48 Vol: Volume 1,983,346 is 49% a...

normal vol

$22.48 Last Close

Volume Volume 1,983,346 is 49% above 20-day average 1,334,209. normal

Technical Price 23.13 is trading below 200-day MA at 28.25 and well under 52-week high 42.50.

Peers on Argus

QDEL was down 1.91% with mixed peer moves: ATEC +1.09%, LIVN +1.73%, PRCT +0.11%...

QDEL was down 1.91% with mixed peer moves: ATEC +1.09%, LIVN +1.73%, PRCT +0.11%, while INSP -0.36% and HAE -0.53%. No broad, aligned sector move is evident.

Historical Context

5 past events · Latest: Feb 11 (Negative)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 11	Earnings results	Negative	-1.4%	Reported FY25 results with large goodwill impairment and 2026 guidance.
Feb 03	Service awards	Positive	+1.2%	Received Excellence Services Label in EMEA and two Stevie awards.
Jan 22	Educational podcast	Positive	+3.9%	Released Science Bytes episode on blood supply pressures and diagnostics.
Jan 21	Earnings date notice	Neutral	-10.1%	Announced timing and access details for upcoming Q4 and FY25 results.
Dec 18	R&D podcast	Positive	-3.6%	Podcast on innovations like high-sensitivity troponin and molecular platforms.

Pattern Detected

Recent news has produced mixed reactions, with operational or thought-leadership items sometimes seeing gains, while scheduling and broader strategic updates have occasionally coincided with selloffs.

Recent Company History

Over the past few months, QuidelOrtho has reported FY25 results with a large goodwill impairment and 2026 guidance, announced service awards and certifications, and promoted podcast content on innovation and blood supply challenges. Earnings-related items, including the Feb 11, 2026 report and the prior earnings-date notice, saw negative reactions, while recognition and educational content sometimes coincided with gains. Today’s conference appearance fits into this pattern of ongoing investor‑relations engagement rather than a discrete financial or clinical catalyst.

Market Pulse Summary

This announcement signals continued investor‑relations outreach, with management presenting at a maj...

Analysis

This announcement signals continued investor‑relations outreach, with management presenting at a major conference on March 3, 2026. It follows recent financial disclosures and governance updates, including FY25 results and leadership changes. The key takeaways relate to visibility and communication rather than new financial or clinical data. Investors may watch for any incremental commentary from the event that clarifies revenue mix, profitability drivers, or strategic priorities in diagnostics.

Key Terms

in vitro diagnostics

1 terms

in vitro diagnostics medical

"QuidelOrtho, a global leader of innovative in vitro diagnostics, today announced..."

In vitro diagnostics are medical tests performed on samples taken from the body—such as blood, urine or tissue—using instruments or kits outside the patient to detect disease, measure biomarkers or guide treatment decisions. They matter to investors because sales, regulatory approvals, reimbursement rules and adoption rates drive companies’ revenue and margins much like product launches and consumer demand in other industries; advances can create growth or disruption in healthcare markets.

AI-generated analysis. Not financial advice.

SAN DIEGO, Feb. 18, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of innovative in vitro diagnostics, today announced that members of its management team will present at the Raymond James 47th Annual Institutional Investor Conference.

The Company's presentation is scheduled for Tuesday, March 3, 2026, at 1:40 p.m. ET / 10:40 a.m. PT. 

Interested parties can access the live webcast and replay in the "Events & Presentations" section of the "Investor Relations" page of QuidelOrtho's website at https://ir.quidelortho.com/.

QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and X.

About QuidelOrtho Corporation

With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global provider of diagnostic solutions, dedicated to advancing fast, accurate and reliable results that help improve patient outcomes – from the point of care to hospital, lab to clinic. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.

Investor Contact:
Juliet Cunningham
Vice President, Investor Relations
IR@QuidelOrtho.com 

Media Contact:
D. Nikki Wheeler
Senior Director, Corporate Communications
media@QuidelOrtho.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/quidelortho-to-present-at-the-47th-annual-raymond-james-institutional-investor-conference-302691849.html

SOURCE QuidelOrtho Corporation

FAQ

When is QuidelOrtho (QDEL) presenting at the Raymond James conference in 2026?

QuidelOrtho will present on March 3, 2026 at 1:40 p.m. ET. According to the company, the presentation is part of the Raymond James 47th Annual Institutional Investor Conference and will be delivered by members of its management team.

How can investors watch the QuidelOrtho (QDEL) presentation on March 3, 2026?

Investors can watch via a live webcast and replay on QuidelOrtho's investor site. According to the company, access is provided in the Events & Presentations section of the Investor Relations page at ir.quidelortho.com.

What time is the QuidelOrtho (QDEL) presentation for Pacific Time viewers on March 3, 2026?

The presentation starts at 10:40 a.m. PT on March 3, 2026. According to the company, that corresponds to 1:40 p.m. ET and will be available live and later as a replay on the investor relations site.

Will QuidelOrtho (QDEL) make the March 3, 2026 presentation available after the event?

Yes, a replay will be available in the Events & Presentations section of its investor site. According to the company, both the live webcast and replay can be accessed on the QuidelOrtho Investor Relations webpage.

Who from QuidelOrtho (QDEL) will present at the Raymond James conference on March 3, 2026?

Members of QuidelOrtho's management team will present at the conference on March 3, 2026. According to the company, attendees can expect senior management participation, with specifics available via the conference agenda and the investor relations webcast.

Where can I find more information about QuidelOrtho (QDEL) and its investor events in 2026?

More information is on QuidelOrtho's corporate and investor pages at quidelortho.com and ir.quidelortho.com. According to the company, event details, webcasts, and replays appear in the Events & Presentations section of Investor Relations.